Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GUFIC BIOSCIENCE Gains 9%; BSE HEALTHCARE Index Down 1.0%
Thu, 3 Oct 9:20

GUFIC BIOSCIENCE Gains 9%; BSE HEALTHCARE Index Down 1.0%Image source: Eoneren/www.istockphoto.com

GUFIC BIOSCIENCE share price has zoomed 9% and is presently trading at Rs 416.9.

Meanwhile, the BSE HEALTHCARE index is at 43,814.5 (down 1.0%).

Among the top gainers in the BSE HEALTHCARE index today are DR. LAL PATHLABS (up 0.7%) and Cadila Healthcare .

KIMS (down 9.6%) and Jubilant Pharmova (down 4.1%) are among the top losers today.

Over the last one year, GUFIC BIOSCIENCE has moved up from Rs 289.8 to Rs 416.9, registering a gain of Rs 127.2 (up 43.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,428.9 to 43,814.5, registering a gain of 54.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 157.1%), SUVEN PHARMACEUTICALS (up 105.3%) and Glenmark Pharma (up 96.0%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 83,002.1 (down 1.5%).

The top losers among the BSE Sensex today are Asian Paints (down 3.0%) and Tata Motors (down 2.9%). The most traded stocks in the BSE Sensex are HDFC Bank and Tata Steel.

In the meantime, NSE Nifty is at 25,452.9 (down 1.3%). BPCL and Bajaj Auto are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,512.1 to 83,002.1, registering a gain of 17,490.0 points (up 26.7%).

GUFIC BIOSCIENCE Financial Update...

GUFIC BIOSCIENCE net profit grew 1.1% YoY to Rs 209 million for the quarter ended June 2024, compared to a profit of Rs 206 million a year ago. Net sales rose 4.0% to Rs 2,028 million during the period as against Rs 1,950 million in April-June 2023.

For the year ended March 2024, GUFIC BIOSCIENCE reported 8.1% increase in net profit to Rs 861 million compared to net profit of Rs 797 million during FY23. Revenue of the company grew 16.8% to Rs 8,067 million during FY24.

The current Price to earnings ratio of GUFIC BIOSCIENCE, based on rolling 12 month earnings, stands at 48.4.


Equitymaster requests your view! Post a comment on "GUFIC BIOSCIENCE Gains 9%; BSE HEALTHCARE Index Down 1.0%". Click here!